Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónWO1995008344 A1
Tipo de publicaciónSolicitud
Número de solicitudPCT/US1994/011225
Fecha de publicación30 Mar 1995
Fecha de presentación22 Sep 1994
Fecha de prioridad22 Sep 1993
También publicado comoCA2172245A1, CA2172245C, DE69430823D1, DE69430823T2, EP0759774A1, EP0759774B1, US5523288, US6140306
Número de publicaciónPCT/1994/11225, PCT/US/1994/011225, PCT/US/1994/11225, PCT/US/94/011225, PCT/US/94/11225, PCT/US1994/011225, PCT/US1994/11225, PCT/US1994011225, PCT/US199411225, PCT/US94/011225, PCT/US94/11225, PCT/US94011225, PCT/US9411225, WO 1995/008344 A1, WO 1995008344 A1, WO 1995008344A1, WO 9508344 A1, WO 9508344A1, WO-A1-1995008344, WO-A1-9508344, WO1995/008344A1, WO1995008344 A1, WO1995008344A1, WO9508344 A1, WO9508344A1
InventoresJonathan Cohen, Ada H. C. Kung, Lewis H. Lambert, Jr., Roger G. Ii Little
SolicitanteXoma Corporation
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos:  Patentscope, Espacenet
Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
WO 1995008344 A1
Descripción  disponible en inglés
Reclamaciones  disponible en inglés
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
WO1989001486A1 *9 Ago 198823 Feb 1989New York UniversityBiologically active bactericidal/permeability-increasing protein fragments
WO1992009621A1 *3 Dic 199111 Jun 1992New York UniversityBiologically active bactericidal/permeability-increasing protein fragments
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
WO1997042966A1 *9 May 199720 Nov 1997Xoma CorporationTherapeutic uses of bpi protein products for human meningococcemia
WO2014160814A1 *26 Mar 20142 Oct 2014Rutgers, The State University Of New JerseySynthetic and enhanced bacterial killing involving bicyclomycin
EP1123102A1 *9 Ago 199916 Ago 2001The Research Foundation Of State University Of New YorkMethod of preventing acute lung injury
EP1123102A4 *9 Ago 199930 Jul 2003Univ New York State Res FoundMethod of preventing acute lung injury
EP1549759A1 *4 Jun 20036 Jul 2005Bayer Healthcare LLCBacterial test method by glycated label binding
EP1549759A4 *4 Jun 20032 Nov 2006Bayer Healthcare LlcBacterial test method by glycated label binding
US5741779 *10 May 199621 Abr 1998Xoma CorporationAntithrombotic materials and methods
US5756464 *10 Sep 199726 May 1998Xoma CorporationTherapeutic uses of BPI protein products in humans with hemmorhage due to trauma
US5856302 *13 Mar 19955 Ene 1999Xoma CorporationTherapeutic uses of bactericidal/permeability-increasing protein dimer products
US5856438 *7 Jun 19955 Ene 1999Xoma CorporationBiologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5858974 *21 Mar 199612 Ene 1999Xoma CorporationAnti-fungal peptides
US5888973 *9 Ago 199630 Mar 1999Xoma CorporationAnti-chlamydial uses of BPI protein products
US5888977 *10 Sep 199730 Mar 1999Giroir; Brett P.Therapeutic uses of BPI protein products for human meningococcemia
US5935930 *20 Abr 199810 Ago 1999Xoma CorporationAntithrombotic materials and methods
US5945399 *23 May 199731 Ago 1999Xoma CorporationTherapeutic uses of BPI protein products in humans with hemorrhage due to trauma
US5990086 *1 Dic 199823 Nov 1999Xoma CorporationTherapeutic uses of BPI protein products for human meningococcemia
US6013631 *19 Jun 199811 Ene 2000Xoma CorporationBactericidal/permeability-increasing protein (BPI) deletion analogs
US6087126 *18 Jun 199911 Jul 2000Xoma CorporationBactericidal/permeability-increasing protein (BPI) deletion analogs
US6093573 *20 Jun 199725 Jul 2000XomaThree-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6107280 *26 Abr 199922 Ago 2000Xoma CorporationAntithrombotic materials and methods
US6162788 *29 Mar 199919 Dic 2000Xoma CorporationUses of BPI protein products
US62424183 Ago 19995 Jun 2001Xoma CorporationTherapeutic uses of BPI protein products for human meningococcemia
US627782130 Dic 199821 Ago 2001Xoma CorporationTherapeutic uses of bactericidal/permeability-increasing protein dimer products
US648279622 Feb 199919 Nov 2002Xoma CorporationTherapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US658311630 Oct 200024 Jun 2003Xoma CorporationAnti-chlamydial methods and materials
US659669130 Nov 200022 Jul 2003Xoma CorporationTherapeutic uses of BPI protein products for human meningococcemia
US659988025 May 200029 Jul 2003Xoma CorporationBactericidal/permeability-increasing protein (BPI) deletion analogs
US65998816 Jul 200029 Jul 2003Xoma CorporationAntithrombotic materials and methods
US729145119 Nov 20046 Nov 2007Xoma Technology Ltd.Modulation of pericyte proliferation
Clasificaciones
Clasificación internacionalA61K38/17, A61K31/505, A61K31/70, A61K31/495, A61K38/00, C07K14/47, A61P31/04, A61K31/65, A61K31/425, A61K31/47, A61K31/535
Clasificación cooperativaC07K14/4742, A61K38/1751
Clasificación europeaA61K38/17A2B29, C07K14/47A29
Eventos legales
FechaCódigoEventoDescripción
30 Mar 1995AKDesignated states
Kind code of ref document: A1
Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA UZ VN
30 Mar 1995ALDesignated countries for regional patents
Kind code of ref document: A1
Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG
22 Jun 1995DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
5 Jul 1995121Ep: the epo has been informed by wipo that ep was designated in this application
12 Mar 1996WWEWipo information: entry into national phase
Ref document number: 275205
Country of ref document: NZ
20 Mar 1996WWEWipo information: entry into national phase
Ref document number: 1994931793
Country of ref document: EP
Ref document number: 2172245
Country of ref document: CA
20 Mar 1996ENPEntry into the national phase in:
Ref country code: CA
Ref document number: 2172245
Kind code of ref document: A
Format of ref document f/p: F
11 Jul 1996REGReference to national code
Ref country code: DE
Ref legal event code: 8642
3 Oct 1996COPCorrected version of pamphlet
Free format text: PAGES 220 AND 221,DESCRIPTION,REPLACED BY NEW PAGES BEARING THE SAME NUMBER;AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY
5 Mar 1997WWPWipo information: published in national office
Ref document number: 1994931793
Country of ref document: EP
12 Jun 2002WWGWipo information: grant in national office
Ref document number: 1994931793
Country of ref document: EP